fbpx

U.S. Anti-Doping Agency (USADA)

Global DRO logo in whiteSearch Medications & Ingredients

Athlete Login >

GlobalDRO >
Medication Search >

U.S. Cycling Athlete Jay Henderson Accepts Sanction for Anti-Doping Rule Violation

December 7, 2017

USADA announced today that Jay Henderson, of Minneapolis, Minn., an athlete in the sport of cycling, has accepted a six-month sanction for an anti-doping rule violation. Henderson was selected to submit a sample as a result of being among the top finishers in his event at the 2017 Green Acres Cyclocross in Lake Elmo, Minn.

Henderson was subject to testing because the event was sanctioned by USA Cycling, which maintains the RaceClean Program that works to fight doping at the amateur level of cycling. The goal of the RaceClean Program is to increase testing and education at the amateur level to provide greater doping deterrence, and this USA Cycling program is executed through member funding, donations, and local association partnerships.

Henderson, 46, tested positive for Carboxy-Tetrahydrocannabinol (THC), a metabolite of marijuana and/or hashish, above the decision limit of 180 ng/mL, as a result of a urine sample collected in-competition on October 14, 2017. Carboxy-THC is a Specified Substance in the class of Cannabinoids and prohibited in-competition under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic Committee National Anti-Doping Policies, and the International Cycling Union Anti-Doping Rules, all of which have adopted the World Anti-Doping Code (the Code) and the World Anti-Doping Agency Prohibited List.

Henderson accepted a six-month period of ineligibility that began on November 13, 2017, the date he accepted a provisional suspension. Based on Henderson’s successful completion of a USADA anti-doping educational tutorial, his period of ineligibility was reduced by three months and is now scheduled to expire on February 12, 2018. In addition, Henderson has been disqualified from competitive results obtained on October 14, 2017, including forfeiture of any medals, points and prizes.

Athletes are advised that the use of a substance or medication out-of-competition, that is prohibited only in-competition, may result in an anti-doping rule violation if the prohibited substance is still present in their body when tested at a competition. USADA cannot predict the clearance time for any substance for any particular individual. If an athlete needs to therapeutically use a substance prohibited in-competition and they are nearing a competition, they are strongly encouraged to contact USADA to learn if they need a Therapeutic Use Exemption (TUE).

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, USADA manages a drug reference hotline, Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

 

Scroll to Top